Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:14:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    403 Forbidden error is now displayed on the page, replacing the usual study record content. This indicates an access or server issue rather than a content update to the trial information.
    Difference
    18%
    Check dated 2026-09-19T19:05:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6, indicating a new version of the page. This update does not alter the study content or related information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:08.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page revision label in the footer changed from v3.6.4 to v3.6.5, indicating an updated build of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-08-08T21:01:22.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page's versioning rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T13:12:30.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new site release. This appears to be a maintenance update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-07-03T23:51:53.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.